Prenetics Global Limited Announces Multi-Year Global Partnership with Giannis Antetokounmpo

Prenetics Global Limited (NASDAQ: PRE), through its premium health and longevity brand IM8, has entered into a multi-year global partnership with NBA Champion Giannis Antetokounmpo. Antetokounmpo will become a Global Partner of IM8 and the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand. This strategic alliance aims to leverage Antetokounmpo's significant global following and influence to expand IM8's market reach, particularly among the 18-34 demographic. The partnership is expected to enhance IM8's cross-sport credibility, following similar equity partnerships with David Beckham, Aryna Sabalenka, and Ollie Bearman. Antetokounmpo's decision to take equity over cash compensation underscores his belief in IM8's potential. IM8, which has achieved $100 million in annualized recurring revenue within 11 months of launch and is projected to generate $180-$200 million in revenue for 2026, will benefit from Antetokounmpo's 35 million social media followers and the NBA's global broadcast reach. The company highlighted its financial stability with approximately $160 million in liquidity and no debt, targeting adjusted EBITDA profitability by Q4 2027. This move is anticipated to be a significant driver for Prenetics shareholders.